Skip to content

Precigen PGEN Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Precigen (PGEN) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $4.25 in Q1 2026.
How has Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price decreased by 9.6% year-over-year, from $4.7 to $4.25.
What is the long-term trend for Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 3 years (2022 to 2025), Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a -25.4% compound annual growth rate (CAGR), from $10.41 to $4.32.